FindTrial
Sign In

Comparison of pain relief between ultrasound guided continuous pericapsular nerve group block and lumbar plexus block after undergoing surgery for unilateral hip fracture.

Continuous ultrasound Pericapsular nerve group block in comparison with ultrasound lumbar plexus block for postoperative pain Management in unilateral hip fracture: A Prospective, randomised, single blind controlled trial study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034895
Enrollment
50
Registered
2021-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: S798- Other specified injuries of hip and thigh

Interventions

Intervention1: Analgesic efficacy of continuous ultrasound pericapsular nerve group block for unilateral hip fracture surgery.: Patient will be given 0.5% of Ropivacaine (15 ml bolus) plus 2 microgra

Sponsors

Government Medical College and Hospital Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: America Society of Anaesthesiologists (ASA) status - I and II Age between 20 - 80 years BMI - 18 - 35 kg/m2 Patients undergoing surgery for unilateral hip fracture

Exclusion criteria

Exclusion criteria: Patient refusal History of drug allergy to ropivacaine and fentanyl Coagulation disorders Cardiovascular, respiratory, and neurological illness Uncontrolled Diabetes Mellitus Local infection Systemic infection Aberrant anatomy of the landmarks Patients having haemodynamic instability Pregnancy and lactating mother Patients who fail to understand pain assessment and usage of PCA pump

Design outcomes

Primary

MeasureTime frame
To compare the mean postoperative pain score over 48 hours using numeric rating scale in patients receiving PENG block vs lumbar plexus blockTimepoint: 5 mins, 10 mins, 15 mins, 1 hour, 4 hours, 8 hours, 12 hours, 24 hours, 36 hours, 48 hours.—

Secondary

MeasureTime frame
To evaluate the difference in motor power and patient satisfaction within the two groups and also note adverse effects, if any, in both groupsTimepoint: 5 mins, 10 mins, 20 mins, 4 hours, at 2 hour intervals till 24 hours, 36 hours, and 48 hours—

Countries

India

Contacts

Public ContactProf Sukanya Mitra

GOVERNMENT MEDICAL COLLEGE HOSPITAL CHANDIGARH

drsmitra12@yahoo.com9646121521

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026